Vascular Grafts Global Market Report 2024

The vascular grafts market size has grown strongly in recent years. It will grow from $3.21 billion in 2023 to $3.5 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth observed in the historical period can be ascribed to factors such as a rise in cardiovascular diseases (CVDs), an increase in the geriatric population, robust economic expansion in emerging markets, an upsurge in healthcare expenditure, and an expansion in the number of healthcare facilities.

The vascular grafts market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth anticipated in the forecast period can be linked to factors such as a rising number of renal diseases, an increase in the prevalence of hypertension, sedentary lifestyles, rapid growth in the geriatric population, a surge in diabetes cases, an increase in cardiovascular diseases (CVDs), and a rise in healthcare expenditure. Key trends in the forecast period involve investments in cutting-edge technology to enhance compliance with smaller vascular grafts, the adoption of technologies such as 3D cell printing for improved safety and ultimately higher success rates, the exploration of cell-free vascular grafts, investments in monitoring technology such as smart patches or self-monitoring devices, and a commitment to research and development for newer and more innovative solutions to enhance patient care.

The global vascular grafts market is experiencing growth, driven by the increasing prevalence of vascular diseases. A study by the National Center for Biotechnology Information in the US reveals that cardiovascular diseases are the leading cause of death worldwide. The American Heart Association (AHA) reports approximately 7.9 million myocardial infarctions annually in the US. The high incidence of vascular diseases, such as coronary artery disease, has led to around 20,000 coronary bypass grafts in England each year. This trend is expected to fuel the demand for vascular grafts globally.

The growth of the vascular grafts market is further propelled by the rising geriatric population. The demographic shift towards an older population, characterized by declining fertility rates and increased life expectancy, is associated with a higher likelihood of developing vascular disorders. Vascular grafts play a crucial role in treating conditions such as aortic dissection in the elderly, repairing damaged aortas and restoring blood flow. The World Health Organization projects a substantial increase in the global population aged 60 and above, reaching 1.4 billion by 2021 and doubling to 2.1 billion by 2050. With a threefold increase expected in those aged 80 or older, the demand for vascular grafts is set to grow significantly.

Companies in the vascular grafts market are actively investing in technological advancements to develop innovative products, including customizable vascular grafts. Terumo Aortic's recent launch of RelayPro, a thoracic stent graft system, exemplifies this trend. This low-profile device caters to patients with smaller access vessels undergoing thoracic endovascular aortic repair (TEVAR). The customizable features, such as diameters, lengths, tapers, and proximal configurations, provide physicians with options tailored to individual patient anatomies.

Major players in the vascular grafts market are focused on introducing innovative products to gain a competitive edge. Innovation in this context refers to the development of advanced technologies to address vascular disorders effectively. For example, in May 2021, Endologix LLC launched the Alto abdominal stent graft system in Canada, representing a significant advancement in polymer-based therapeutics for abdominal aortic aneurysms (AAA). The device's unique conformable sealing ring and low-profile delivery system aim to overcome the limitations of traditional vascular grafts.

In August 2022, Gore & Associates, a US-based materials science company, acquired InnAVasc Medical Inc., a US-based manufacturer of vascular grafts for hemodialysis. This strategic move is anticipated to enhance patient outcomes and improve dialysis treatment for individuals with end-stage renal disease, highlighting the industry's commitment to continuous advancement.

Major companies operating in the vascular grafts market report are B. Braun Melsungen AG, Abbott Laboratories, Becton Dickinson and Company, Cardinal Health Inc., W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic PLC, Getinge, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Creganna, Novomed Incorporation Private Limited, Marizyme Inc., Terumo Corporation, Gore Medical, LeMaitre Vascular, Olympus Medical Systems Corporation, Japan Lifeline, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Kips Bay Medical Incorporated, Cryolife, Vascular Graft Solutions Ltd.

North America was the largest region in the vascular grafts market in 2023. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The primary products within the vascular grafts market include hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts. The term 'endovascular stent graft' denotes a minimally invasive approach employed for treating aortic aneurysms, used to assess the presence of abdominal pain, disease symptoms, and the size of the aneurysm. Raw materials utilized encompass polyester grafts, ePTFE, polyurethane grafts, and biosynthetic grafts. Vascular grafts serve various applications such as coronary artery disease, aneurysms, vascular occlusion, and renal failure, with hospitals and ambulatory surgical centers being the primary end-users.

The vascular grafts market research report is one of a series of new reports that provides vascular grafts market statistics, including vascular grafts industry global market size, regional shares, competitors with a vascular grafts market share, detailed vascular grafts market segments, market trends and opportunities, and any further data you may need to thrive in the vascular grafts industry. This vascular grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular grafts market consists of sales of polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), or a different person's vein (allograft). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.